Author: digi

Communications After Trial Completion: Results Sharing and Lay Summaries In the field of clinical trials, effective communication post-trial completion is essential for maintaining transparency and public trust. This comprehensive guide will navigate the key steps involved in sharing trial results and preparing lay summaries, with a focus on the mavacamten clinical trial and the implications…

Read More “Communications After Trial Completion: Results Sharing and Lay Summaries” »

Building Community Engagement Strategies That Support Ethical Trial Conduct Building Community Engagement Strategies That Support Ethical Trial Conduct Introduction to Community Engagement in Clinical Trials Community engagement is an essential component of clinical trials, especially in the context of ethical trial conduct. It refers to the processes by which researchers engage with the community to…

Read More “Building Community Engagement Strategies That Support Ethical Trial Conduct” »

Public Trust in Clinical Research: Lessons for Sponsors and Investigators Public Trust in Clinical Research: Lessons for Sponsors and Investigators Understanding Public Trust in Clinical Research Public trust in clinical research plays a pivotal role in the integrity and success of clinical trials. The perception of transparency, ethical conduct, and community involvement can significantly influence…

Read More “Public Trust in Clinical Research: Lessons for Sponsors and Investigators” »

Establishing Community Advisory Boards for High-Impact Studies Establishing Community Advisory Boards for High-Impact Studies Community Advisory Boards (CABs) play a pivotal role in enhancing the ethical conduct of clinical trials, particularly in sensitive health-related areas such as prostate cancer clinical trials. This article outlines a comprehensive step-by-step guide for clinical operations, regulatory affairs, and medical…

Read More “Establishing Community Advisory Boards for High-Impact Studies” »

Engaging Patient Advocacy Groups in Protocol and Consent Development Engaging Patient Advocacy Groups in Protocol and Consent Development Effective engagement with patient advocacy groups is vital in the planning and execution of clinical trials. Prostate cancer clinical trials, in particular, can benefit significantly from incorporating insights and contributions from patient advocacy organizations. This guide provides…

Read More “Engaging Patient Advocacy Groups in Protocol and Consent Development” »

Two-Way Communication Plans With Communities Before, During and After Trials Engagement with the communities surrounding clinical trials is paramount for the ethical and effective conduct of clinical research. This article provides a comprehensive, step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU to establish effective two-way communication…

Read More “Two-Way Communication Plans With Communities Before, During and After Trials” »